Biogen Inc. is a company in the U.S. stock market and it is a holding in 227 U.S.-traded ETFs. BIIB has around 15.7M shares in the U.S. ETF market. The largest ETF holder of BIIB is the Invesco QQQ Trust (QQQ), with approximately 1.91M shares. Investors may also find of interest that the ETF with the largest allocation to BIIB stock is VanEck Vectors Biotech ETF (BBH), with a portfolio weight of 5.08%. On average, U.S. ETFs allocate 0.49% of BIIB to their portfolios.
Additionally, BIIB is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with BIIB as a holding is the iShares Morningstar U.S. Equity ETF (ILCB), with a return of 498.40%.